A group of researchers has found a new way to limit excessive immune responses, which may point in a new direction for research in and treatment of e.g. autoimmune diseases.
Researchers from Aarhus University Hospital and Aarhus University in Denmark in collaboration with researchers from Colorado in the United States have found a new way to treat the inflammation involved in chronic diseases such as psoriasis, asthma and HIV. A group of transmitter substances (cytokines) in the immune system, the so-called IL-1 family, has been shown to play an important role in many of these diseases by regulating the body’s immune responses.
Professor Charles A. Dinarello from University of Colorado Denver is also an honorary doctor at Aarhus University. He is an expert in regulation and transmission of these cytokines. He is primarily known for discovering the important cytokine IL-1(-?), which plays an important role in countless diseases. In collaboration with Charles Dinarello, the Danish researchers have investigated a more efficient way of reducing the effect of the IL-1 family and in this way improve treatment of chronic inflammatory diseases.
Previous research has often focused on blocking a single cytokine or signaling pathway at a time. However, many diseases and sequela are driven by more than one cytokine. This has caused researchers to wonder if it could be possible to block more important signaling pathways of the IL-1 family at the same time, and in this way make it possible to develop better treatments. The researchers try to find a broader anti-inflammatory treatment impacting several important cytokines at the same time, but also trying to avoid that this causes unintended side-effects.
In this study, the researchers have investigated if a receptor (IL-1R3), which is not just involved in the signaling of one but six different inflammatory cytokines in the IL-1 family, could be a possible target in the treatment of chronic inflammatory disease. Using an antibody to block the effect of IL-1R3, it was possible for the researchers to investigate the effects in both studies on cells and mice.
In this way, researchers could study some of the consequences of the blocking of this receptor on the immune system. At the same time, the researchers specifically studied the effect of blocking IL-1R3 in mice with either gout, acute allergic inflammation (asthma) or psoriasis.
– The experiments showed that it was possible to effectively block the receptor and reduce manifestation of diseases, which underlines the potentials in our new approach, says MD and PhD Jesper Falkesgaard Højen.
– Even though new questions arise as a consequences of these results, we have managed to describe a new and effective approach to block IL-1 family driven inflammation, and in this way we have possibly contributed with a new direction to study and treat chronic inflammatory conditions driven by the IL-1 family.
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- Humans and autoimmune diseases continue to evolve togetheron November 28, 2019 at 9:09 am
The ability to fight disease is a driving force in human survival. Inflammation has emerged as a key weapon in this process. As pathogens change and evolve, the immune system adapts to keep up. Share ...
- Roles of aminoacyl-tRNA synthetases in immune regulation and immune diseaseson November 28, 2019 at 5:25 am
Meanwhile, we describe the functional mechanisms of ARSs in the development of immune cells. In addition, we focus on the roles of ARSs in certain immune diseases, such as autoimmune diseases, ...
- Worldwide Autoimmune Disease Diagnostics Market Analysis and Outlook, 2018-2019 and 2025 - ResearchAndMarkets.comon November 27, 2019 at 4:12 pm
The "Autoimmune Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025" report has been added to ResearchAndMarkets.com's offering. This report includes the latest predictions ...
- Humans co-evolved with immune-related diseases -- and it's still happeningon November 27, 2019 at 1:37 pm
Some of the same mutations allowing humans to fend off deadly infections also make us more prone to certain inflammatory and autoimmune diseases, such as Crohn's disease. Researchers describe how ...
- Autoimmune Disease Drug Market Is Projected to Grow at a CAGR of 4.3 % During the Forecast Periodon November 27, 2019 at 9:00 am
Pune, India -- (SBWIRE) -- 11/27/2019 -- Infinium Global Research has added a new report on "Autoimmune Disease Drug Market (Indication - Diabetes Mellitus Type 1, Rheumatic Diseases, Multiple ...
- New method enables easier and faster detection of celiac disease antibodieson November 27, 2019 at 6:04 am
This technology could revolutionize the serodiagnosis of microbial, autoimmune and allergic disorders. Now this team of researchers have applied the new concept for diagnostics of celiac disease. Most ...
- The Trick of Treating Cancer in Autoimmune Diseaseson November 25, 2019 at 6:15 pm
"But for patients with autoimmune disease, it comes with a catch." Immunotherapy helps a patient's immune system locate and destroy tumor cells, he explained here at the American College of ...
- Autoimmune Disease Diagnostics Market Comprehensive Analysis, Share, Growth Forecast from 2018 to 2024on November 21, 2019 at 9:19 pm
Nov 22, 2019 (AmericaNewsHour) -- Market Study Report LLC has recently added a report on Autoimmune Disease Diagnostics Market which provides a succinct analysis of the market size, revenue forecast, ...
- Global Autoimmune Partnering Deal Trends, Players and Financials Directory 2019on November 21, 2019 at 3:41 pm
Global Autoimmune Partnering 2014 to 2019 provides the full collection of Autoimmune disease deals signed between the world's pharmaceutical and biotechnology companies since 2014. Most of the deals ...
- Could sphingolipids help solve a racial paradox in heart disease?on November 20, 2019 at 1:32 pm
Complicating this narrative, however, is the higher risk of severe heart disease in African Americans, despite the fact that they tend to have higher levels of HDL and lower levels of triglycerides.
via Bing News